SALL4 and benign neoplasm: Therefore, in the present study, the clinical significance and prognostic value of the co-expression of SALL4/ALDH1A1 were investigated with various clinicopathological features and survival outcomes by applying the IHC technique on TMA sections in patients with SOC, benign tumors, and normal ovarian samples.